Elimination of cervical cancer: challenges for developing countries
- PMID: 31921346
- PMCID: PMC6946419
- DOI: 10.3332/ecancer.2019.975
Elimination of cervical cancer: challenges for developing countries
Abstract
Cervical cancer is one of the most preventable cancers today, yet over 500,000 new cases are diagnosed globally each year and every 2 minutes a woman dies from cervical cancer. The burden of this disease and the highest mortality from cervical cancer occur in developing countries. High-income countries are poised to eliminate cervical cancer in the 21st century, but despite a global call to eliminate this disease, low- and middle-income countries face many challenges as they strive to answer that call.
Keywords: HPV testing; cervical cancer; disparities in care; human papillomavirus (HPV) vaccination; prevention; screening; visual inspection with acetic acid.
© the authors; licensee ecancermedicalscience.
Conflict of interest statement
The author has no conflicts of interest to declare.
Similar articles
-
Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.Womens Health (Lond). 2020 Jan-Dec;16:1745506520914804. doi: 10.1177/1745506520914804. Womens Health (Lond). 2020. PMID: 32364058 Free PMC article. Review.
-
Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.Minerva Ginecol. 2019 Oct;71(5):365-371. doi: 10.23736/S0026-4784.19.04468-X. Minerva Ginecol. 2019. PMID: 31698891 Review.
-
The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:47-56. doi: 10.1002/ijgo.12184. Int J Gynaecol Obstet. 2017. PMID: 28691334
-
Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.BMC Public Health. 2020 Jan 31;20(1):142. doi: 10.1186/s12889-020-8216-9. BMC Public Health. 2020. PMID: 32005202 Free PMC article. Clinical Trial.
-
Mega Hpv laboratories for cervical cancer control: Challenges and recommendations from a case study of Turkey.Papillomavirus Res. 2019 Jun;7:118-122. doi: 10.1016/j.pvr.2019.03.002. Epub 2019 Mar 13. Papillomavirus Res. 2019. PMID: 30878532 Free PMC article.
Cited by
-
Knowledge, Attitude and Practice Concerning Cervical Cancer Screening Among Reproductive Age Group Women in Low-Resource Settings Yenagoa Bayelsa State.Niger Med J. 2024 Sep 26;65(4):512-523. doi: 10.60787/nmj-v65i3-492. eCollection 2024 Jul-Aug. Niger Med J. 2024. PMID: 39398398 Free PMC article.
-
Acceptability and Concordance of Self- Versus Clinician- Sampling for HPV Testing among Rural South Indian Women.Asian Pac J Cancer Prev. 2021 Mar 1;22(3):971-976. doi: 10.31557/APJCP.2021.22.3.971. Asian Pac J Cancer Prev. 2021. PMID: 33773563 Free PMC article.
-
Impact of Parental Knowledge and Beliefs on HPV Vaccine Hesitancy in Kenya-Findings and Implications.Vaccines (Basel). 2022 Jul 26;10(8):1185. doi: 10.3390/vaccines10081185. Vaccines (Basel). 2022. PMID: 35893833 Free PMC article.
-
Utility of expression of 4-hydroxynonenal tested by immunohistochemistry for cervical cancer.Prz Menopauzalny. 2024 Mar;23(1):6-13. doi: 10.5114/pm.2024.136356. Epub 2024 Mar 18. Prz Menopauzalny. 2024. PMID: 38690070 Free PMC article.
-
Strategies to eliminate cervical cancer in China.Front Oncol. 2023 Jun 2;13:1105468. doi: 10.3389/fonc.2023.1105468. eCollection 2023. Front Oncol. 2023. PMID: 37333817 Free PMC article. Review.
References
-
- The American cancer society-key statics for cervical cancer. 2019. [13/07/19]. [ www.cancer.org/cancer/cervical-cancer/about/key-statistics.html]
-
- World Health Organization. Geneva: World Health Organization; 2018. Accelerating cervical cancer elimination. Report by the Director-General EB144/28 Cervical Cancer Initiative.
LinkOut - more resources
Full Text Sources
Miscellaneous